Comparison of 18F-Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (18F-FDG PET/CT) and conventional imaging (CI) for locally advanced breast cancer staging: a prospective study from a tertiary hospital cancer centre in Western Cape
| dc.contributor.advisor | Parkes, Jeannette | |
| dc.contributor.author | Chilwesa, Paul Mambwe | |
| dc.date.accessioned | 2020-03-02T11:35:37Z | |
| dc.date.available | 2020-03-02T11:35:37Z | |
| dc.date.issued | 2019 | |
| dc.date.updated | 2020-03-02T09:40:54Z | |
| dc.description.abstract | Background: Breast cancer is the second most common cancer in adults and the most frequent cancer diagnosed in women. In South Africa, breast cancer accounts for 38.5% of cancers diagnosed in women. Since the presence, extent and location of distant metastases is one important prognostic factor in locally advanced breast cancer (LABC), accurate staging at diagnosis is crucial to ensure patients receive the appropriate treatment. Increasing evidence shows that the use of 18F-FDG PET/CT for disease staging of LABC may improve diagnostic sensitivity. Aim: To prospectively assess the difference in diagnostic accuracy between whole-body PET/PET-CT and conventional imagine (CI) for staging LABC. Methods: A total of 42 participants with clinical stage III and a select few stage II breast cancer underwent both 18F-FDG PET/CT and CI. Results: 18F-FDG PET/CT found significantly more (p=0.0077) distant metastatic sites than CI (36% vs. 21%). 18F-FDG PET/CT upstaged 9 (21.4%) of patients from clinical stage IIIa to stage IIIc, and changed management of 54% of patients. Thirty-eight percent (38%) of the patients had their clinical stage unchanged. One of 5 suspected metastatic sites 18F FDG PET/CT was positive for malignancy on biopsy. Conclusion: The 18F-FDG PET/CT is useful for staging locally advanced non-inflammatory infiltrating ductal carcinoma of the breast. Use of 18F-FDG PET/CT was superior to conventional imaging in assessing metastatic mediastinal lymphadenopathy, but with a poor specificity. The use of 18F-FDG PET/CT in LABC is useful, with the biopsy of isolated suspicious lesions for metastasis increasing its accuracy. | |
| dc.identifier.apacitation | Chilwesa, P. M. (2019). <i>Comparison of 18F-Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (18F-FDG PET/CT) and conventional imaging (CI) for locally advanced breast cancer staging: a prospective study from a tertiary hospital cancer centre in Western Cape</i>. (). ,Faculty of Health Sciences ,Department of Radiation Medicine. Retrieved from http://hdl.handle.net/11427/31433 | en_ZA |
| dc.identifier.chicagocitation | Chilwesa, Paul Mambwe. <i>"Comparison of 18F-Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (18F-FDG PET/CT) and conventional imaging (CI) for locally advanced breast cancer staging: a prospective study from a tertiary hospital cancer centre in Western Cape."</i> ., ,Faculty of Health Sciences ,Department of Radiation Medicine, 2019. http://hdl.handle.net/11427/31433 | en_ZA |
| dc.identifier.citation | Chilwesa, P.M. 2019. Comparison of 18F-Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (18F-FDG PET/CT) and conventional imaging (CI) for locally advanced breast cancer staging: a prospective study from a tertiary hospital cancer centre in Western Cape. . ,Faculty of Health Sciences ,Department of Radiation Medicine. http://hdl.handle.net/11427/31433 | en_ZA |
| dc.identifier.ris | TY - Thesis / Dissertation AU - Chilwesa, Paul Mambwe AB - Background: Breast cancer is the second most common cancer in adults and the most frequent cancer diagnosed in women. In South Africa, breast cancer accounts for 38.5% of cancers diagnosed in women. Since the presence, extent and location of distant metastases is one important prognostic factor in locally advanced breast cancer (LABC), accurate staging at diagnosis is crucial to ensure patients receive the appropriate treatment. Increasing evidence shows that the use of 18F-FDG PET/CT for disease staging of LABC may improve diagnostic sensitivity. Aim: To prospectively assess the difference in diagnostic accuracy between whole-body PET/PET-CT and conventional imagine (CI) for staging LABC. Methods: A total of 42 participants with clinical stage III and a select few stage II breast cancer underwent both 18F-FDG PET/CT and CI. Results: 18F-FDG PET/CT found significantly more (p=0.0077) distant metastatic sites than CI (36% vs. 21%). 18F-FDG PET/CT upstaged 9 (21.4%) of patients from clinical stage IIIa to stage IIIc, and changed management of 54% of patients. Thirty-eight percent (38%) of the patients had their clinical stage unchanged. One of 5 suspected metastatic sites 18F FDG PET/CT was positive for malignancy on biopsy. Conclusion: The 18F-FDG PET/CT is useful for staging locally advanced non-inflammatory infiltrating ductal carcinoma of the breast. Use of 18F-FDG PET/CT was superior to conventional imaging in assessing metastatic mediastinal lymphadenopathy, but with a poor specificity. The use of 18F-FDG PET/CT in LABC is useful, with the biopsy of isolated suspicious lesions for metastasis increasing its accuracy. DA - 2019 DB - OpenUCT DP - University of Cape Town KW - Locally advanced breast cancer KW - NACT KW - 18F-FDG PET/CT KW - Conventional imaging KW - Staging KW - South Africa LK - https://open.uct.ac.za PY - 2019 T1 - Comparison of 18F-Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (18F-FDG PET/CT) and conventional imaging (CI) for locally advanced breast cancer staging: a prospective study from a tertiary hospital cancer centre in Western Cape TI - Comparison of 18F-Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (18F-FDG PET/CT) and conventional imaging (CI) for locally advanced breast cancer staging: a prospective study from a tertiary hospital cancer centre in Western Cape UR - http://hdl.handle.net/11427/31433 ER - | en_ZA |
| dc.identifier.uri | http://hdl.handle.net/11427/31433 | |
| dc.identifier.vancouvercitation | Chilwesa PM. Comparison of 18F-Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (18F-FDG PET/CT) and conventional imaging (CI) for locally advanced breast cancer staging: a prospective study from a tertiary hospital cancer centre in Western Cape. []. ,Faculty of Health Sciences ,Department of Radiation Medicine, 2019 [cited yyyy month dd]. Available from: http://hdl.handle.net/11427/31433 | en_ZA |
| dc.language.rfc3066 | eng | |
| dc.publisher.department | Department of Radiation Medicine | |
| dc.publisher.faculty | Faculty of Health Sciences | |
| dc.subject | Locally advanced breast cancer | |
| dc.subject | NACT | |
| dc.subject | 18F-FDG PET/CT | |
| dc.subject | Conventional imaging | |
| dc.subject | Staging | |
| dc.subject | South Africa | |
| dc.title | Comparison of 18F-Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (18F-FDG PET/CT) and conventional imaging (CI) for locally advanced breast cancer staging: a prospective study from a tertiary hospital cancer centre in Western Cape | |
| dc.type | Master Thesis | |
| dc.type.qualificationlevel | Masters | |
| dc.type.qualificationname | MMed |